Walden Venture Capital

Walden Venture Capital is a U.S. venture capital firm focused primarily on early-stage "Sprout Stage" investments rather than operating as a drug-development company. The firm has historically invested across technology, consumer, digital media, cloud services, and selected healthcare or digital health opportunities, but it is not itself a biotech, pharma, or healthcare operating company. Walden describes its strategy as backing teams with demonstrated breakthrough technology, product, or brand potential and typically investing in early institutional rounds. The organization has a long operating history dating to 1974 and is associated with offices in the San Francisco Bay Area/Woodside, California.